https://orcid.org/0000-0003-4408-3357
References
- Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochimica et biophysica acta. Rev Cancer. 2020;1873(1):188314
- Li J, Li H, Zeng H, et al. Trends in high-risk rates and screening rates for the population-based cancer screening program on esophageal, stomach and liver cancer in China, 2010-2016. J National Cancer Center. 2021;1(3):101–107.
- Chang X, Wang J, Ni CF. Value of Mir-1271 and GPC3 in prognosis evaluation of liver cancer patients after liver transarterial chemoembolization. Oncologie. 2021;23(1):119–130.
- Ma X, Ding Y, Zeng L. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma. BMC Cancer. 2021;21(1):418.
- Wang Z, Wu R, Nie Q, et al. Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance. J National Cancer Center. 2021;1(1):15–22
- Syed KM, Joseph S, Mukherjee A, et al. Histone chaperone APLF regulates induction of pluripotency in murine fibroblasts. J Cell Sci. 2016;129(24):4576–4591.
- Nixon RA. The role of autophagy in neurodegenerative disease. Nature Med. 2013;19(8):983–997.
- Zhang D, Zhang W, Sun R, et al. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data. Bioengineered. 2021;12(1):1091–1110.
- Liu T, Ma Q, Li W, et al. Ubiquilin 1 suppresses the cancer stem cell-like traits of non-small cell lung cancer cells by regulating reactive oxygen species homeostasis. Bioengineered. 2021;12(1):7143–7155.
- Liao F, Hu X, Chen R. The effects of Omarigliptin on promoting osteoblastic differentiation. Bioengineered. 2021;12(2):11837–11846.
- Chen X, Zhang H, Li L, et al. miR-5100 mediates migration and invasion of melanomatous cells in vitro via targeting SPINK5. J Compr Mol Sci Genet. 2021;1:14–23.
- Qian B, Ying X, Yang G, et al. TRIP13 is identified as a prognosis biomarker for renal clear cell carcinoma and promotes renal cell carcinoma cell proliferation, migration and invasion. Biocell. 2021;45(3):577–588.
- Stolz A, Ernst A, Dikic I. Cargo recognition and trafficking in selective autophagy. Nature Cell Biol. 2014;16(6):495–501.
- O’Rourke EJ, Ruvkun G. MXL-3 and HLH-30 transcriptionally link lipolysis and autophagy to nutrient availability. Nature Cell Biol. 2013;15(6):668–676.
- Singh SS, Vats S, Chia AY-Q, et al. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018;37(9):1142–1158.
- Fukushima H, Yamashina S, Arakawa A, et al. Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatol Res. 2018;48(9):757–767.
- Wu P, Gao M, Dong J, et al. The role of mTOR signaling pathway in regulating autophagy in liver injury of TX mice with Wilson’s disease. Biocell. 2021;45(1):109–117.
- Yeganeh B, Rezaei Moghadam, A, Alizadeh, J, et al. Hepatitis B and C virus-induced hepatitis: apoptosis, autophagy, and unfolded protein response. World J Gastroenterol. 2015;21(47):13225–13239.
- Lin Y, Wu C, Wang X, et al. Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling. Autophagy. 2020;16(3):548–561.
- Shin GC, Kang HS, Lee AR, et al. Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response. Autophagy. 2016;12(12):2451–2466.
- Xie N, Yuan K, Zhou L, et al. PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation. Autophagy. 2016;12(9):1507–1520.